Agilent Technologies and BioNanomatrix to Develop Genetic Analysis System Using Nanoscale Whole Genome Imaging Technology
Agilent Technologies Inc. and BioNanomatrix Inc. announced that they have entered into a collaboration to develop a new genetic analysis system combining the two companies' technologies. BioNanomatrix, which develops breakthrough nanoscale whole genome imaging and analytic platforms, will apply its innovative nanoscale single molecule imaging technology to develop consumable chips and reagents, while Agilent will develop the measurement instrumentation platform for the system.
BioNanomatrix is developing pioneering technology that enables nanoscale single molecule identification and analysis of the entire genome, delivering single-molecule sensitivity in a highly parallel format. The company's patented analytic platform based on this technology has the potential to provide rapid, comprehensive and cost-effective ultra-high resolution analyses of DNA. The two companies intend to collaborate closely in the development of an integrated system and applications.
"BioNanomatrix's unique nanoscale whole genome imaging and analysis technology, with sensitivity at the level of the single molecule, has the potential to enable a number of important new applications for life sciences research and clinical medicine," said Nick Roelofs, vice president and general manager of the Life Sciences Solutions Unit at Agilent. "We are committed to continuing our leadership in developing important new technologies and solutions for our customers, and we look forward to collaborating with the BioNanomatrix team to enable these powerful new capabilities to reach the marketplace."
Further details of the agreement were not disclosed.
Other news from the department business & finance
These products might interest you
Blotting standards and reagents by Cytiva
Western blotting standards and reagents
Blotting the course to effective detection of proteins from sample preparation to analysis
Micro-Dx™ CE IVD by Molzym
Fully automated from sample to PCR analysis
Rapid identification of bacteria and fungi without time-consuming cultivation
DNA-free Taq Polymerases and Mastermixes by Molzym
DNA-free reagents for unrivalled sensitivity in molecular biology
Purity that makes the difference
Greener Alternative Products by Merck
Sustainable laboratory products for environmentally conscious research
Over 2,500 ecological alternatives to reduce your laboratory footprint
Most read news
More news from our other portals
Last viewed contents
LDC opens branch in Munich - Focus on discovery of therapeutic antibodies
Structure of key protein for cell division puzzles researchers - Researchers provide a first 3D snapshot of the CCAN protein complex and raise fundamental questions towards the creation of artificial chromosomes
Banti's_syndrome
BASF and Catalent join forces to solve bioavailability challenges
Positive Results from Phase II VTE Prophylaxis Study with TB-402 (Anti-Factor VIII) - Study demonstrates TB-402 superior antithrombotic activity to enoxaparin
Atheris_squamigera
Creutzfeldt-Jakob_disease
Second-Generation COVID-19 Vaccine Candidate Demonstrates High Immunogenicity Against Virus Variants in Preclinical Study - Fast onset of strong neutralizing antibody titers after first vaccination
Pfizer Provides Update on Two R&D Pipeline Developments
Regenesys BVBA - Leuven (Heverlee), Belgium
The_Constant_Gardener
